Magnetic resonance imaging (MRI) can spare many patients with rectal cancer from invasive surgery that can carry lifelong side effects, new research indicates. That information could be extremely ...

Some rectal cancer patients might be spared surgery and the lifelong need for a colostomy bag if they undergo MRI screening, a new study finds. The scans might accurately predict which patients have a ...

Magnetic resonance imaging (MRI) can spare many patients with rectal cancer from invasive surgery that can carry lifelong side effects, new research indicates. The findings, from UVA Cancer Center's ...

Please provide your email address to receive an email when new articles are posted on . MRI can help determine which individuals with rectal cancer may not need surgery following neoadjuvant therapy.

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors A clinical and magnetic resonance imaging ...

MRI response categories predict organ preservation, local regrowth, and survival in rectal cancer patients post-neoadjuvant therapy. Restricted diffusion and abnormal nodal features on MRI indicate ...

Holman Day is Stanford Surgery's annual celebration of science. The Holman Lecture Series and Research Day commemorates the life and accomplishments of Founding Department Chair Emile Frederic Holman, ...

Neoadjuvant therapy has become a cornerstone in the management of locally advanced rectal cancer (LARC). In this single-arm, open-label phase II study, we evaluated the efficacy and safety of total ...

MRI can predict the risk of rectal cancer reccurring or spreading for patients who have undergone chemotherapy and radiation, new research indicates. Magnetic resonance imaging (MRI) can spare many ...

Magnetic resonance imaging (MRI) can spare many patients with rectal cancer from invasive surgery that can carry lifelong side effects, new research indicates. The findings, from UVA Cancer Center's ...

“No one wants to get surgery if they can avoid it. Now we have a powerful tool to help patients and their doctors predict who would benefit from surgery after initial chemotherapy and radiation and ...